RxDoctor Payments Data

Richard Lapp

Family Medicine · Orlando, FLNPI 1346459401

Payments from drug & device makers

$701,583in general payments, 2019–2025

Across 695 payments — averaging $1009.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$277K
  • CSL Plasma Inc.$236K
  • Kedplasma LLC$188K
  • Incyte Corporation$240
  • Bristol Myers Squibb$125
  • AstraZeneca$110
  • plus $192 from 2 others
$950in research payments, 2019–2025

Across 1 payment — averaging $950.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Emergent Biosolutions Inc.$950

What the payments were for

  • Consulting fees$700,916100%
  • Food & beverage$6670%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$701,583 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Other family medicine in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →